Inventor · disambiguated record
Shai Yarkoni
Also filed as: YARKONI SHAI
10 granted patents·15 pending applications·117 citations·filing 1996–2019
89Inventor score
Files withYISSUM RES DEV CO9CELLECT BIOTHERAPEUTICS LTD6PINES MARK2YARKONI SHAI2CELLECT BIOTECHNOLOGY LTD1
Top patents by PatentIndex Score
25 records- 0175US7704506B2Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the sameYISSUM RES DEV CO·Filed 2007·Granted Apr 27, 2010·2 cites·2 claims
- 0275US6645490B2Chimeric proteins with cell-targeting specificity and apoptosis-inducing activitiesYISSUM RES DEV CO·Filed 1998·Granted Nov 11, 2003·29 cites·12 claims
- 0371US2009181894A1Chimeric toxins for targeted therapyYISSUM RES DEV CO·Filed 2009·Application pending·0 cites
- 0469US2009317358A1Chimeric proteins with cell-targeting specificity and apoptosis-inducing activitiesYISSUM RES DEV CO·Filed 2009·Application pending·0 cites
- 0568US9783778B2Devices and methods for selecting apoptosis-signaling resistant cells, and uses thereofCELLECT BIOTECHNOLOGY LTD·Filed 2013·Granted Oct 10, 2017·1 cites·16 claims
- 0668US6140066AMethods of cancer diagnosis using a chimeric toxinFiled 1998·Granted Oct 31, 2000·37 cites·37 claims
- 0761US7740853B2Fcepsilon-pe chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the sameYISSUM RES DEV CO·Filed 2002·Granted Jun 22, 2010·2 cites·4 claims
- 0860US2005256049A1Chimeric toxins for targeted therapyYISSUM RES DEV CO·Filed 2005·Application pending·0 cites
- 0954US6531133B1Pseudomonas exotoxin-myelin basic protein chimeric proteinsYISSUM RES DEV CO·Filed 1996·Granted Mar 11, 2003·26 cites·14 claims
- 1054US2005079154A1Chimeric proteins with cell-targeting specificity and apoptosis-inducing activitiesYISSUM RES AND DEV COMPANY·Filed 2003·Application pending·0 cites
- 1153US2008255339A1Chimeric proteins with cell-targeting specificity and apoptosis-inducing activitiesYISSUM RES DEV CO·Filed 2002·Application pending·0 cites
- 1251US6919079B1FcεPE chimeric protein for targeted treatment of allergy responses, a method for its production and pharmaceutical compositions containing the sameYISSUM RES COMPANY OF THE HEBR·Filed 1996·Granted Jul 19, 2005·13 cites·7 claims
- 1350US2006194822A1Treatment for renal fibrosisNAGLER ARNON·Filed 2005·Application pending·0 cites
- 1449US2006258692A1Quinazolinone compositions for regulation of gene expression related to pathological processesPINES MARK·Filed 2003·Application pending·0 cites
- 1548US2004171627A1Treatment of renal fibrosisHADASIT·Filed 2003·Application pending·0 cites
- 1647US2006009475A1Quinazolinone compounds in combined modalities for improved cancer treatmentPINES MARK·Filed 2002·Application pending·0 cites
- 1746US2021322474A1Modulation of apoptosis susceptible cellsCELLECT BIOTHERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1844US6933271B2Chimeric toxins for targeted therapyYISSUM RES DEV CO·Filed 1997·Granted Aug 23, 2005·7 cites·23 claims
- 1943US2005222182A1Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivativesYARKONI SHAI·Filed 2005·Application pending·0 cites
- 2043US2018208888A1Devices and methods for selecting apoptosis-signaling resistant cells, and uses thereofCELLECT BIOTHERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 2142US2021137990A1Methods for exp anding adipose-derived stem cellsCELLECT BIOTHERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2238US2016263158A1Activation of hematopoietic progenitors by pretransplant exposure to death ligandsCELLECT BIOTHERAPEUTICS LTD·Filed 2014·Application pending·0 cites
- 2335US11578306B2Methods for propagating mesenchymal stem cells (MSC) for use in transplantationCELLECT BIOTHERAPEUTICS LTD·Filed 2016·Granted Feb 14, 2023·0 cites·6 claims
- 2430US9624469B2Regulatory immune cells with enhanced targeted cell death effectYARKONI SHAI·Filed 2011·Granted Apr 18, 2017·0 cites·4 claims
- 2525US2018163173A1Selective surfaces for, and methods of, selecting a population of stem and progenitor cells, and uses thereofCELLECT BIOTHERAPEUTICS LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shai Yarkoni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →